Cargando…
The frequency of assessment of progression in randomized oncology clinical trials
BACKGROUND: Progression in tumor assessments is often detected at a follow‐up appointment rather than when actual change in progression has occurred, which can bias PFS outcomes. AIM: We sought to evaluate the frequency of tumor assessment scans in clinical trials of anti‐cancer interventions and to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327664/ https://www.ncbi.nlm.nih.gov/pubmed/34821077 http://dx.doi.org/10.1002/cnr2.1527 |